William Annett

Jun 16, 2015

William Annett has been appointed CEO of OncoCyte, succeeding Joseph Wagner who led the firm in the early stages of clinical development of its products. Annett has been a member of OncoCyte's board since January, and he previously served as managing director at Accenture. He was also CEO of BioFX Laboratories and founded and led Corra Life Sciences.